SPDR Advertisement SureTrader SPDR Advertisement SPDR Advertisement
Home > Boards > US Listed > Miscellaneous > Rigel Pharmaceuticals Inc. (RIGL)

7:40AM On The Wires (WIRES) :

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
surf1944 Member Profile
 
Followed By 450
Posts 21,999
Boards Moderated 2
Alias Born 09/11/06
160x600 placeholder
Midday Gainers / Losers "Seeking Alpha" - 2/23/2015 12:44:12 PM
Rigel and Bristol-Myers Squibb Announce Research and Development Collaboration for TGF Beta Receptor Kinase Inhibitors for Us... "PR Newswire (US)" - 2/23/2015 8:03:00 AM
Rigel & Bristol-Myers Squibb Announce Research & Development Collaboration for TGF Beta Receptor Kinase Inhibitors for Use in... "Business Wire" - 2/23/2015 8:00:00 AM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 2/18/2015 6:09:01 AM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 2/17/2015 11:10:51 AM
Lion Biotechnologies Appoints Ryan Maynard Director and Chair of Audit Committee "GlobeNewswire Inc." - 2/17/2015 8:00:00 AM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 2/13/2015 10:35:10 AM
Schedule 13g
(sc 13g/a) "Edgar (US Regulatory)" - 2/12/2015 10:54:56 AM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 2/9/2015 4:48:15 PM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 2/9/2015 2:24:01 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/30/2015 4:06:20 PM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 1/26/2015 5:20:14 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/9/2015 4:16:33 PM
Rigel to Present at the 33rd Annual J.P. Morgan Healthcare Conference "PR Newswire (US)" - 1/8/2015 7:30:00 AM
Amended Statement of Changes in Beneficial Ownership (4/a) "Edgar (US Regulatory)" - 12/22/2014 6:27:38 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/24/2014 4:16:19 PM
Rigel Announces Executive Management Changes "PR Newswire (US)" - 11/24/2014 7:30:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/4/2014 4:20:12 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 11/4/2014 1:47:09 PM
Rigel Announces Third Quarter 2014 Financial Results "PR Newswire (US)" - 11/4/2014 7:30:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/5/2014 6:06:39 PM
U.S. Hot Stocks: Hot Stocks to Watch "Dow Jones News" - 8/13/2014 9:47:19 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/13/2014 8:00:35 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/5/2014 4:05:33 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 8/5/2014 1:20:59 PM
surf1944   Friday, 05/06/11 09:58:11 AM
Re: surf1944 post# 130
Post # of 321 
7:40AM On The Wires (WIRES) :

Rigel Pharmaceuticals, Inc. (RIGL) announced that the company will assume development of R343, its inhaled syk inhibitor for allergic asthma that recently completed several Phase 1 clinical trials. Pfizer (PFE) is returning full rights to the R343 program as a result of its decision to exit the allergy and respiratory therapeutic area within R&D. Rigel is evaluating the details of R343's development to date and expects to design a Phase 2 clinical trial with R343 later this year.


surf's up......crikey



Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist